Cargando…

Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage

Background: Primary hyperaldosteronism (PA) develops due to abnormality in the zona glomerulosa of the adrenal gland which results in excessive production of aldosterone. Primary hyperaldosteronism remains an important cause of secondary hypertension. Subarachnoid hemorrhage is a pathological condit...

Descripción completa

Detalles Bibliográficos
Autores principales: Panikar, Krish, Ganesh1, H K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067824/
http://dx.doi.org/10.4103/2230-8210.342243
_version_ 1784700093317775360
author Panikar, Krish
Ganesh1, H K
author_facet Panikar, Krish
Ganesh1, H K
author_sort Panikar, Krish
collection PubMed
description Background: Primary hyperaldosteronism (PA) develops due to abnormality in the zona glomerulosa of the adrenal gland which results in excessive production of aldosterone. Primary hyperaldosteronism remains an important cause of secondary hypertension. Subarachnoid hemorrhage is a pathological condition in which the blood enters the subarachnoid space. Case Presentation: A 32 year old female presented with complains of uncontrolled hypertension on antihypertensive drugs. She gives history of a subarachnoid hemorrhage Examination revealed a BP of 170/100 mmhg which was not controlled on antihypertensive agents. Blood test showed a potassium level of 2.7 mmol/l [3.5-5 mmol/l], creatinine 0.9 mg/dl [0.7-1.4], Hb 10.5 gm/dl on the basis of the preliminary blood tests a serum Aldosterone levels were asked which showed 23.7 ng/dl [2-9 ng/dl] A CECT abdomen was done which revealed a lesion in the medial limb of the right adrenal gland. Conclusion: Primary hyperaldosteronism is an under diagnosed entity and has a higher mortality and morbidity when compared to individuals with essential hypertension. PA should be suspected in all individuals with resistant hypertension even those on multiple drugs and who develop hypokalemia.
format Online
Article
Text
id pubmed-9067824
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-90678242022-05-05 Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage Panikar, Krish Ganesh1, H K Indian J Endocrinol Metab Abstracts … Esicon 2021 Background: Primary hyperaldosteronism (PA) develops due to abnormality in the zona glomerulosa of the adrenal gland which results in excessive production of aldosterone. Primary hyperaldosteronism remains an important cause of secondary hypertension. Subarachnoid hemorrhage is a pathological condition in which the blood enters the subarachnoid space. Case Presentation: A 32 year old female presented with complains of uncontrolled hypertension on antihypertensive drugs. She gives history of a subarachnoid hemorrhage Examination revealed a BP of 170/100 mmhg which was not controlled on antihypertensive agents. Blood test showed a potassium level of 2.7 mmol/l [3.5-5 mmol/l], creatinine 0.9 mg/dl [0.7-1.4], Hb 10.5 gm/dl on the basis of the preliminary blood tests a serum Aldosterone levels were asked which showed 23.7 ng/dl [2-9 ng/dl] A CECT abdomen was done which revealed a lesion in the medial limb of the right adrenal gland. Conclusion: Primary hyperaldosteronism is an under diagnosed entity and has a higher mortality and morbidity when compared to individuals with essential hypertension. PA should be suspected in all individuals with resistant hypertension even those on multiple drugs and who develop hypokalemia. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9067824/ http://dx.doi.org/10.4103/2230-8210.342243 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Abstracts … Esicon 2021
Panikar, Krish
Ganesh1, H K
Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage
title Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage
title_full Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage
title_fullStr Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage
title_full_unstemmed Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage
title_short Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage
title_sort abstract 118: primary hyperaldosteronism presenting as subarachnoid hemorrhage
topic Abstracts … Esicon 2021
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067824/
http://dx.doi.org/10.4103/2230-8210.342243
work_keys_str_mv AT panikarkrish abstract118primaryhyperaldosteronismpresentingassubarachnoidhemorrhage
AT ganesh1hk abstract118primaryhyperaldosteronismpresentingassubarachnoidhemorrhage